ArticleCase reports in transplantation2017

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation.

Luca Lanfranco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.